These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28856406)

  • 41. Involvement of neurotransmitters in the action of the nociceptin/orphanin FQ peptide-receptor system on passive avoidance learning in rats.
    Palotai M; Adamik A; Telegdy G
    Neurochem Res; 2014 Aug; 39(8):1477-83. PubMed ID: 24893797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blockade of the nociceptin/orphanin FQ/NOP receptor system in the rat ventrolateral periaqueductal gray potentiates DAMGO analgesia.
    Scoto GM; Aricò G; Ronsisvalle S; Parenti C
    Peptides; 2007 Jul; 28(7):1441-6. PubMed ID: 17628212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions.
    Broccardo M; Linari G; Guerrini R; Agostini S; Petrella C; Improta G
    Peptides; 2005 Sep; 26(9):1590-7. PubMed ID: 16112397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.
    Molinari S; Camarda V; Rizzi A; Marzola G; Salvadori S; Marzola E; Molinari P; McDonald J; Ko MC; Lambert DG; Calo' G; Guerrini R
    Br J Pharmacol; 2013 Jan; 168(1):151-62. PubMed ID: 22827708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPA.
    Marti M; Trapella C; Morari M
    J Neurochem; 2008 Dec; 107(6):1683-96. PubMed ID: 19014386
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dorsal raphe nucleus 5-Hydroxytryptamine 2A receptors are critical for the organisation of panic attack-like defensive behaviour and unconditioned fear-induced antinociception elicited by the chemical stimulation of superior colliculus neurons.
    da Silva Soares R; Falconi-Sobrinho LL; Almada RC; Coimbra NC
    Eur Neuropsychopharmacol; 2019 Jul; 29(7):858-870. PubMed ID: 31227263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
    Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
    Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NOP receptor antagonist, JTC-801, blocks cannabinoid-evoked hypothermia in rats.
    Rawls SM; Schroeder JA; Ding Z; Rodriguez T; Zaveri N
    Neuropeptides; 2007 Aug; 41(4):239-47. PubMed ID: 17512052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway.
    Marti M; Trapella C; Viaro R; Morari M
    J Neurosci; 2007 Feb; 27(6):1297-307. PubMed ID: 17287504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NOP receptor mediates anti-analgesia induced by agonist-antagonist opioids.
    Gear RW; Bogen O; Ferrari LF; Green PG; Levine JD
    Neuroscience; 2014 Jan; 257():139-48. PubMed ID: 24188792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anticonvulsant action of GABA receptor blockade in the nigrotectal target region.
    Dean P; Gale K
    Brain Res; 1989 Jan; 477(1-2):391-5. PubMed ID: 2539235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice.
    Walentiny DM; Wiebelhaus JM; Beardsley PM
    Drug Alcohol Depend; 2018 Jun; 187():335-342. PubMed ID: 29705547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recruitment of striatonigral disinhibitory and nigrotectal inhibitory GABAergic pathways during the organization of defensive behavior by mice in a dangerous environment with the venomous snake Bothrops alternatus (Reptilia, Viperidae).
    Almada RC; Coimbra NC
    Synapse; 2015 Jun; 69(6):299-313. PubMed ID: 25727065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
    Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endogenous nociceptin/orphanin FQ (N/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naïve and nociceptin/orphanin FQ receptor knockout mice.
    Mabrouk OS; Marti M; Morari M
    Neuroscience; 2010 Mar; 166(1):40-8. PubMed ID: 20006677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nociceptin/orphanin FQ opioid peptide (NOP) receptor and µ-opioid peptide (MOP) receptors both contribute to the anti-hypersensitive effect of cebranopadol in a rat model of arthritic pain.
    Schiene K; Schröder W; Linz K; Frosch S; Tzschentke TM; Jansen U; Christoph T
    Eur J Pharmacol; 2018 Aug; 832():90-95. PubMed ID: 29753041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex.
    Mela F; Marti M; Ulazzi L; Vaccari E; Zucchini S; Trapella C; Salvadori S; Beani L; Bianchi C; Morari M
    Eur J Neurosci; 2004 Mar; 19(5):1317-24. PubMed ID: 15016089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stimulation of the Nigrotectal Pathway at the Level of the Superior Colliculus Reduces Threat Recognition and Causes a Shift From Avoidance to Approach Behavior.
    Almada RC; Genewsky AJ; Heinz DE; Kaplick PM; Coimbra NC; Wotjak CT
    Front Neural Circuits; 2018; 12():36. PubMed ID: 29867370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine.
    Ding Z; Raffa RB
    Br J Pharmacol; 2009 Jul; 157(5):831-43. PubMed ID: 19422392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: behavioral and electrophysiological studies in mice.
    Nazzaro C; Rizzi A; Salvadori S; Guerrini R; Regoli D; Zeilhofer HU; Calo G
    Peptides; 2007 Mar; 28(3):663-9. PubMed ID: 17161885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.